Evidence Synthesis
Here is the rewritten narrative in the requested format: Auropharma's quarterly GROSS_MARGIN accelerated to 58.85%, up from 15.24%.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 14 Sept 2026, 00:17
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
Here is the rewritten narrative in the requested format: Auropharma's quarterly GROSS_MARGIN accelerated to 58.85%, up from 15.24%.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 58.85 % | 15.24 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 15.24 % | 10.63 | ▲ |
| REVENUE_GROWTH_YOY | 16.3 % | 25.8 | ▼ |
| EPS_ACTUAL | 14.61 INR | 16.434 | ▼ |
| EPS_SURPRISE_PERCENT | -0.041 % | 0.035 | ▼ |
| PRICE_CHANGE_PERCENT | 0.683 % | — | - |
| DAILY_VOLUME | 4,94,251 shares | 11,24,509 | ▼ |
| CLOSE_PRICE | 1,679.8 INR | 1,668.4 | ▲ |
| NEWS_SENTIMENT_SCORE | 0.52 score | — | - |
| ANALYST_STRONG_BUY_COUNT | 5 count | 13 | ▼ |
| TARGET_PRICE_PREMIUM | 0.58 % | — | - |